The Hormonal Rhythm of Metabolism: How Your Monthly Cycle Shapes Appetite, Fat-Burning, and Energy

Most of us think of the menstrual cycle as a purely reproductive rhythm — an ebb and flow of hormones whose primary job is to prepare the body for a possible pregnancy. But your cycle is also a powerful metabolic rhythm. It changes the way you burn fuel, how hungry you feel, your mood, and even how well you respond to fasting or exercise.

These changes aren’t random — they’re part of a finely tuned evolutionary design. Across the month, your body alternates between a high-performance, fat-burning mode and a nutrient-conserving, fat-storing mode, depending on where you are in your cycle. Understanding this pattern means you can align your diet, fasting, and training with your biology rather than against it.

And here’s the kicker: this isn’t just about women. Men don’t have a monthly cycle in the same way, but their testosterone follows a daily rhythm (peaking in the morning) and a longer-term seasonal pattern that can subtly influence mood, motivation, and metabolism. For women, the hormonal shifts are more pronounced, predictable, and tied to reproductive phases — making them an underused tool in nutrition and fitness planning.

What We’ll Cover

In this blog, we’ll explore:

• How oestrogen, progesterone, and other hormones affect appetite, fuel use, and metabolism across the menstrual cycle.

• The evolutionary logic behind these shifts — why your body burns fat more easily at some times and stores it more readily at others.

• Phase-specific strategies for fasting, nutrition, and training that work with your hormones, not against them.

• Menopause transitions — how the hormonal drop reshapes metabolism and how to adapt.

• The male comparison — why men’s hormone cycles are different, and what patterns they follow.

The Hormonal Landscape

Your cycle can be divided into two main phases — the follicular phase (from menstruation to ovulation) and the luteal phase (from ovulation to the start of your next period). Oestrogen dominates the first half, making you more insulin-sensitive, less hungry, and better at burning fat. Progesterone takes the lead in the second half, increasing appetite, slightly reducing insulin sensitivity, and shifting your body toward glucose use and fat storage.

Then, menopause marks a new chapter: oestrogen and progesterone both drop, removing many of the protective metabolic effects you enjoyed earlier in life, but also bringing new opportunities to adjust your nutrition, fasting, and training for long-term health.

The Monthly Hormonal Symphony and Metabolism

Your menstrual cycle is usually split into two main phases:

Follicular phase (Day 1 to ovulation):

• Oestrogen (estradiol) steadily rises, peaking just before ovulation.

• Progesterone is low.

• Insulin sensitivity is higher, meaning your cells respond better to insulin, so glucose is used efficiently, and your body is more inclined to burn fat.

• Appetite often decreases due to oestrogen’s effects on the hypothalamus and on ghrelin (the “hunger hormone”).

• Fat oxidation (fat-burning) is upregulated, making this a “metabolically flexible” period.

• Fasting tolerance tends to be higher — fewer cravings, stable energy.

Technical Version - Feel free to skip

During the follicular phase, estrogen levels rise progressively, peaking just before ovulation. This hormone exerts anorexigenic (appetite-suppressing) effects primarily through estrogen receptor alpha (ERα) in the hypothalamus, particularly in the arcuate nucleus (ARC) and ventromedial nucleus (VMH). Estrogen enhances the activity of pro-opiomelanocortin (POMC) neurons, which promote satiety, and mimics the effects of leptin (a hormone that signals fullness) by activating Stat3 signaling pathways. It also potentiates cholecystokinin (CCK), a gut hormone that reduces meal size.

• Impact on Appetite: Estrogen suppresses hunger by reducing levels of orexigenic (appetite-stimulating) neuropeptides like neuropeptide Y (NPY) and ghrelin. Studies show lower food intake in this phase, with women reporting reduced cravings and emotional eating. For instance, a narrative review of dietary energy intake found that estrogen-dominant periods correlate with decreased calorie consumption, potentially due to its antagonistic effects on progesterone's appetite-stimulating actions.

• Impact on Fat/Glucose Burning: Estrogen promotes lipolysis (fat breakdown) and fat oxidation by upregulating genes involved in fatty acid metabolism, such as peroxisome proliferator-activated receptor alpha (PPARα) in skeletal muscle. This shifts metabolism toward using fat as fuel, especially during exercise. Research on metabolic patterns indicates higher fat utilization in the follicular phase compared to luteal, with trends of increased acylcarnitines (markers of fatty acid oxidation) around ovulation. Glucose oxidation remains balanced, but estrogen improves insulin sensitivity, facilitating efficient glucose uptake without excessive storage.

This makes the follicular phase ideal for fasting or fat-loss strategies, as your body is primed for lower hunger and enhanced fat mobilization. However, acute exercise doesn't significantly alter appetite hormones differently between phases in active women, suggesting these effects are more pronounced at rest or with chronic habits.

Luteal phase (Post-ovulation to menstruation):

• Progesterone rises significantly, while oestrogen dips (there’s a smaller second oestrogen peak, but it’s lower than pre-ovulation).

• Progesterone raises body temperature, slightly increasing basal metabolic rate (BMR), but paradoxically increases appetite — particularly for carbohydrate-rich, energy-dense foods.

• Progesterone ramps up energy use (thermogenesis, endometrial growth, immune work).

• To compensate, it also ramps up appetite (via NPY, cravings).

• The net effect: the body aims for a positive or at least neutral energy balance.

So the logic is:

• “I’m burning slightly more energy now → better eat more, especially carbs and fats → so if I conceive, I’m not starting off in an energy deficit.”

• Insulin sensitivity drops, and the body shifts more toward glucose metabolism and fat storage — an evolutionary “energy stocking” mechanism in case of pregnancy.

• Fasting feels harder — blood sugar swings and hunger signals increase.

Technical Version - Feel free to skip

After ovulation, progesterone surges (often 10–20 times higher than in the follicular phase), while estrogen remains elevated but begins to decline. Progesterone acts via progesterone receptors in the brain and periphery, often counteracting estrogen's effects. It can stimulate appetite by increasing NPY expression and modulating serotonin levels, which dip in this phase and contribute to cravings (especially for carbs and sweets). In women with PMS or PMDD, these changes are amplified, linking to altered serotonin influenced by progesterone peaks.

• Impact on Appetite: Progesterone promotes hyperphagia (increased eating), leading to higher calorie intake—often 200–500 extra calories daily. This is tied to elevated energy demands for potential pregnancy, with studies showing increased protein and carbohydrate consumption correlating positively with progesterone levels. Appetite-regulating hormones like ghrelin may not differ markedly between phases, but subjective hunger and cravings rise, particularly for high-energy foods. A proteomics study on appetite regulation noted challenges in maintaining consistent intake due to these fluctuations, with progesterone reversing estrogen's suppressive effects.

• Impact on Fat/Glucose Burning: Metabolism shifts toward anabolic processes, favoring fat storage and glucose utilization for energy. Progesterone increases lipid synthesis (e.g., for endometrial thickening), reducing plasma phospholipids and enhancing fat absorption. Glucose levels drop in the luteal phase, potentially due to heightened insulin signaling for storage, while fat oxidation decreases. This makes prolonged fasting harder, as the body prioritizes carb intake to meet demands—aligning with recommendations for low-carb eating to manage blood sugar and cravings.

Overall, the luteal phase's progesterone dominance creates a "storage mode," which can hinder fat loss but supports recovery and nutrient replenishment.

Modern mismatch

• In the ancestral environment, luteal-phase eating would have meant more roots, tubers, seasonal fruits, or animal fat → relatively limited, whole-food calories.

• In today’s world, it often means ice cream, pastries, bread, chocolate → hyper-available, calorie-dense foods.

• That mismatch is why many women notice PMS cravings leading to water retention and weight gain.

Image Credit: Wikipedia

Menopause: Estrogen Decline and Shifts in Appetite and Metabolism

Menopause marks the end of menstrual cycles, with estrogen levels dropping dramatically (progesterone also falls but to a lesser extent). This deficiency disrupts hypothalamic regulation, leading to central leptin insensitivity and increased expression of appetite-stimulating factors like NPY and melanin-concentrating hormone (MCH). Estrogen's protective effects on ERα pathways are lost, contributing to hyperphagia and weight gain.

• Impact on Appetite: Without estrogen's suppression, appetite increases, often with a preference for high-calorie foods. Studies link this to reduced modulation of ghrelin and CCK, resulting in larger meal sizes and emotional eating. Estrogen deficiency in hypothalamic nuclei like the ARC and PVN exacerbates this, as seen in animal models where ovariectomy (simulating menopause) causes overeating reversible by estrogen replacement.

• Impact on Fat/Glucose Burning: Metabolism slows, with a shift toward glucose burning over fat due to impaired insulin sensitivity and reduced fat oxidation. Estrogen normally enhances glucose transporters (e.g., GLUT4) and suppresses hepatic glucose production; its loss leads to insulin resistance, higher blood sugar, and easier fat storage, especially visceral (abdominal) fat. This "android" distribution increases metabolic syndrome risk, as visceral fat promotes inflammation and further insulin issues. However, a 2022 study challenges the idea of complete fat-burning impairment, finding that postmenopausal women can still utilize fat effectively during exercise if energy balance is negative (e.g., via calorie deficit or activity), with no major differences from premenopausal women when fitness levels are similar. This suggests lifestyle interventions like fasting or low-carb diets can manage these shifts, though they may require adjustments for reduced estrogen.

In summary, while estrogen fosters a lean, fat-burning state in the follicular phase, progesterone tips the scale toward storage in the luteal phase. Menopause amplifies storage tendencies but is manageable with targeted strategies, emphasizing the importance of monitoring individual responses and consulting healthcare providers for personalized advice.

Image Credit: EverydayHealth

Key Hormones & Neurochemicals in Play

Understanding your monthly metabolic shifts starts with knowing the main players and how they interact.

Oestrogen

• What it does: Peaks in the follicular phase; boosts fat oxidation, improves insulin sensitivity, enhances mood and motivation, and suppresses appetite.

• Diet/Lifestyle levers: Cruciferous vegetables (broccoli, kale, cauliflower) for oestrogen metabolism; omega-3s for anti-inflammatory balance; strength training for insulin sensitivity.

Progesterone

• What it does: Dominates in the luteal phase; increases appetite, raises body temperature, can cause water retention, and shifts the body toward glucose use over fat-burning.

• Diet/Lifestyle levers: Balanced protein and healthy fats to stabilise blood sugar; magnesium-rich foods to ease PMS; avoid extreme fasting or calorie restriction in this phase.

LH (Luteinising Hormone) & FSH (Follicle-Stimulating Hormone)

• What they do: Trigger ovulation and regulate follicle development; indirectly influence energy and mood through reproductive readiness signals.

• Diet/Lifestyle levers: Adequate protein, healthy fats, and micronutrients (zinc, selenium, folate) to support ovulatory health; manage stress to prevent LH suppression.

Insulin

• What it does: Regulates blood sugar and fat storage; more sensitive in the follicular phase, more resistant in the luteal phase.

• Diet/Lifestyle levers: Lower-carb meals in luteal phase to offset reduced sensitivity; resistance training year-round to maintain insulin sensitivity.

Cortisol

• What it does: Stress hormone; chronic elevation can disrupt ovulation, increase cravings, and promote abdominal fat storage.

• Diet/Lifestyle levers: Prioritise sleep, stress-reducing practices (yoga, breathwork, prayer), moderate-intensity exercise over high-stress endurance training.

Serotonin

• What it does: Mood regulator; levels can drop in the luteal phase, contributing to PMS mood swings and carb cravings (since carbs help boost serotonin).

• Diet/Lifestyle levers: Tryptophan-rich foods (turkey, pumpkin seeds, oats) with healthy carbs to support serotonin; light exposure and exercise to enhance natural production.

Dopamine

• What it does: Motivation and reward chemical; generally higher during follicular phase, enhancing drive and focus.

• Diet/Lifestyle levers: Tyrosine-rich foods (eggs, beef, lentils); goal-oriented exercise; novelty and learning new skills to boost dopamine tone.

Oxytocin

• What it does: “Bonding hormone” — surges during ovulation and intimacy; promotes social connection and reduces stress.

• Diet/Lifestyle levers: Physical affection, social interaction, even spending time with pets; moderate exercise like dancing or group sports.

Menstrual Cycle Metabolic Patterns – with Evolutionary Context

Factor	Early Follicular (Days 1–7)	Late Follicular → Ovulation (Days 8–14)	Early–Mid Luteal (Days 15–24)	Late Luteal / PMS (Days 25–28)
Dominant hormones	Oestrogen rising from low; progesterone low	Oestrogen peaks; LH surge; progesterone still low	Progesterone dominant; smaller oestrogen peak	Progesterone falling; oestrogen falling
Appetite	Lower or steady	Often suppressed	Increasing	Highest, carb-heavy cravings
Insulin sensitivity	Higher	Highest	Falling	Lowest
Preferred fuel tilt	More fat oxidation	Fat-burning and metabolic flexibility	Slight shift to glucose use and storage	More glucose use; easier fat storage
Metabolic notes	Stable mood/energy for most; cramps/low iron for some	Peak motivation, recovery, and pain tolerance	Body temp + BMR up; fluid shifts	Sleep dips; mood/craving volatility
Best fasting approach	14–16 h TRE if suits you	Easiest time for longer fasts (16–18 h)	Shorter fasts (12–14 h) or regular meals	Skip long fasts; consistent meals
Nutrition focus	Whole-food carbs tolerated; protein; iron if needed	Lean protein, fibre, colourful plants; carbs around training	Lower refined carbs; protein, fibre, potassium-rich foods	Protein, omega-3s, magnesium-rich foods; limit sugar/alcohol
Training focus	Technique work; moderate strength; light cardio if crampy	Heavier strength, power, intervals	Steady cardio, moderate strength	Deload: walks, mobility, light lifting
Key nutrients for hormones, mood & metabolism	Iron (red meat, lentils, spinach), Vitamin C for absorption, Omega-3s, B vitamins, magnesium	Omega-3s (salmon, chia), zinc (pumpkin seeds), Vitamin D, colourful antioxidants (berries), healthy fats for hormone synthesis (avocado, olive oil)	Magnesium (nuts, dark chocolate), B6 (poultry, bananas) to support progesterone and mood, potassium (leafy greens, sweet potatoes), omega-3s	Magnesium (dark leafy greens, pumpkin seeds), omega-3s, B6, tryptophan (turkey, oats), healthy fats (nuts, seeds) to support serotonin and mood stability
Evolutionary “why”	Energy is conserved for recovery after menstruation; appetite stable so foraging/social activity can resume without distraction	Fertile window — body optimises energy use, boosts mood/motivation, and suppresses appetite to prioritise mating and mobility	Possible pregnancy — body begins conserving energy, increasing nutrient storage, and raising appetite to prepare for foetal demands	If no conception, hormonal drop triggers pre-menstrual symptoms; cravings drive calorie-dense eating to offset potential early pregnancy or blood loss

Menopause & Post-Menopause – with Evolutionary Context

Factor	Perimenopause → Menopause
Hormonal pattern	Declining/erratic oestrogen; lower progesterone overall
Appetite	Tends to increase
Insulin sensitivity	Tends to decrease
Fuel tilt	More glucose use; fat loss harder
Key shifts	Visceral fat risk up; sleep variability; hot flushes
Fasting approach	Gentle TRE (12–16 h) if feels good; avoid aggressive fasts if sleep/stress suffer
Nutrition focus	Higher protein (1.6–2.0 g/kg/d), fibre, limit refined carbs; phytoestrogens; calcium/vitamin D
Training focus	Resistance training 2–4×/week, daily movement, balance/power work
Key nutrients for hormones, mood & metabolism	Calcium, Vitamin D, magnesium for bone/muscle health; omega-3s for heart and brain; phytoestrogens (soy, flax, legumes) for oestrogen-like support; B vitamins for energy; protein to offset anabolic resistance
Evolutionary “why”	Post-reproductive stage frees women from pregnancy/infant care risk, allowing greater role in survival of offspring/grandchildren (“grandmother effect”), but hormonal drop removes protective metabolic effects, so diet and lifestyle become the main defences

Why Evolution Designed It This Way

From an evolutionary standpoint, this monthly metabolic swing had clear survival advantages:

• Follicular phase (fat-burning bias): High oestrogen in the fertile window boosts energy, sharpens mood, and suppresses appetite — perfect for foraging, socialising, and finding a mate. Your body is primed for mobility, not storage.

• Luteal phase (fat-storing bias): After ovulation, your biology assumes pregnancy is possible. Increased appetite and reduced insulin sensitivity help you stock up on calories and nutrients to support a potential foetus.

• Menopause: Freed from pregnancy risks, women historically played a key role in the survival of the group — the “grandmother effect.” But the loss of oestrogen means metabolism shifts toward glucose preference and fat storage, requiring dietary and lifestyle adaptations.

How Men Compare

Men don’t have a monthly rhythm like women, but their testosterone follows:

• A daily cycle, peaking in the early morning and dipping in the evening.

• A yearly cycle, often highest in late summer/early autumn and lowest in late winter (influenced by light exposure, activity, and body fat).

Testosterone supports muscle mass, metabolic rate, and motivation — so men’s fasting, training, and dietary responses can subtly vary across the day and year, but the swings are smaller and less behaviourally obvious than in women.

The Takeaway

Once you understand that your monthly cycle is more than a reproductive calendar, it becomes a metabolic map. By aligning fasting windows, carb intake, and training intensity to the natural ebb and flow of oestrogen and progesterone, you can:

• Make fasting easier and more effective.

• Support stable mood and energy.

• Reduce cravings and overeating in your high-appetite phases.

• Preserve muscle and metabolic flexibility in menopause.

Your hormones aren’t an obstacle — they’re a built-in performance guide. Work with them, and you’ll get better results with less struggle.

How to Spot Your Phase Without a Calendar

You don’t always need an app or diary to figure out where you are in your cycle. Your body gives you clues:

Follicular phase (Day 1–14)

• Appetite is lower, especially for sweets and carbs.

• Energy and mood feel more stable; motivation is higher.

• Workouts feel easier, and you recover faster.

• Skin may look clearer and more vibrant as oestrogen rises.

Luteal phase (Day 15–28)

• Appetite increases — particularly for comfort carbs or salty snacks.

• You may notice more bloating or fluid retention.

• Body temperature is slightly higher; you may feel warmer during workouts.

• Mood can dip, with more irritability or anxiety before menstruation.

Menopause/perimenopause

• Cycle cues may become inconsistent or disappear.

• Sleep quality, hot flushes, and mood swings become better indicators than a strict calendar.

Note: If you’re not sure, track for one or two months — note appetite, energy, mood, and any cravings. Patterns emerge surprisingly quickly, and you’ll start predicting your “fat-burning” and “fuel-storing” phases without thinking about it.

Leveraging Your Hormonal Rhythm to Optimise Fertility

If you’re trying to conceive, understanding the monthly dance of hormones isn’t just about mood and metabolism — it’s about creating the most fertile internal environment possible. By aligning your nutrition, activity, and lifestyle habits with your hormonal shifts, you can support ovulation quality, endometrial receptivity, and overall reproductive health.

From an evolutionary perspective, these shifts are nature’s way of maximising the odds of conception when conditions are ideal. The body allocates resources, adjusts energy use, and fine-tunes the immune system to favour reproduction during fertile windows and to protect a potential pregnancy during the luteal phase.

For Women

Follicular phase (Days 1–14)

• Goal: Support egg development and prepare the body for ovulation.

• Nutrition: Colourful antioxidant-rich plants (berries, leafy greens, cruciferous veg) protect developing follicles from oxidative stress. Omega-3 fats (salmon, sardines, chia) improve egg quality and regulate inflammation.

• Micronutrients: Zinc (pumpkin seeds, oysters), selenium (Brazil nuts), folate (lentils, leafy greens), iron (red meat, legumes) — all critical for healthy ovulation.

• Lifestyle: Strength training and moderate cardio improve blood flow to reproductive organs and support insulin sensitivity, both important for ovulatory health.

• Stress: Keep cortisol low — high stress can delay or blunt the LH surge that triggers ovulation.

• Evolutionary why: In our ancestral past, this was the “seek and attract” phase — high energy, sharp mood, and peak fertility combined to maximise mating success.

Ovulation window (~Days 12–16)

• Goal: Maximise chances of fertilisation.

• Nutrition: Stay hydrated, eat anti-inflammatory foods, and avoid heavy alcohol or excessive caffeine (both can impair cervical mucus quality).

• Lifestyle: Sexual activity every 1–2 days during this window ensures sperm are present when the egg is released.

• Evolutionary why: The fertile window was the most energy-rich and socially active time of the month — a built-in strategy to coincide peak sociability and attractiveness with maximum fertility.

Luteal phase (Days 15–28)

• Goal: Support implantation and early pregnancy.

• Nutrition: Protein, healthy fats (avocado, olive oil, nuts), and B6 (poultry, bananas) support progesterone production. Magnesium (leafy greens, pumpkin seeds) helps reduce anxiety and cramping.

• Lifestyle: Gentle exercise like walking, yoga, or light strength keeps blood flowing without adding stress. Avoid extreme fasting or calorie restriction — this is a nutrient-demand phase.

• Stress: High stress can shorten the luteal phase, making implantation harder.

• Evolutionary why: In a possible pregnancy scenario, the body shifts to conserve energy and store nutrients, while the immune system subtly changes to support embryo survival.

For Men

Men don’t follow a monthly cycle, but sperm health responds to lifestyle, nutrition, and circadian rhythm over weeks and months. Since sperm take 70–90 days to mature, habits today shape fertility several months ahead.

• Nutrition:

  • Zinc (oysters, pumpkin seeds) for sperm count and motility.

  • Omega-3 fats for sperm membrane flexibility.

  • Antioxidants like Vitamin C (citrus, peppers) and Vitamin E (nuts, seeds) to protect sperm DNA.

  • Selenium (Brazil nuts) for sperm morphology.

• Lifestyle:

  • Avoid prolonged heat exposure to testes (hot baths, laptops on lap, tight cycling gear).

  • Limit alcohol and ultra-processed food — both impair sperm motility.

  • Strength training and regular activity improve testosterone levels, supporting sperm production.

  • Prioritise 7–8 hours of sleep to maintain testosterone rhythm.

• Stress management: Chronic stress raises cortisol, which suppresses testosterone and sperm quality.

• Evolutionary why: In ancestral settings, men’s reproductive readiness was less tied to monthly cycles and more to overall health, energy reserves, and social dominance — all of which influence modern sperm quality and mating success.

Final Thoughts: Turning Hormones Into an Advantage

Your monthly cycle isn’t just about reproduction — it’s a built-in performance schedule. Every hormonal shift you experience has a biological purpose rooted in survival. In the follicular phase, you’re primed to move, burn fat, and take on challenges. In the luteal phase, your body prepares to nourish and conserve. In menopause, you transition into a new metabolic landscape that still offers strength, resilience, and vitality — if you work with it.

Instead of fighting cravings, energy dips, or appetite changes, you can anticipate them. By syncing your fasting, food choices, and training to your hormonal rhythm, you’re not only improving metabolism and body composition — you’re protecting your mood, energy, and long-term health.

Your hormones aren’t the enemy. They’re the original biohack — refined over millions of years to help you survive and thrive. When you learn to work with their rhythm, you unlock a level of ease and effectiveness that no one-size-fits-all diet can match.

---

📢 A Note on "Living Science"

Science is not a static destination; it is a moving target. While the principles of Turnover, Signaling, and Tension are grounded in decades of metabolic research, new peer-reviewed data emerges every day.

I am committed to accuracy. If you are a researcher, clinician, or dedicated student of physiology and you find a piece of data here that does not align with the latest high-quality evidence, please reach out. I welcome civil, evidence-based corrections. My goal is to keep this resource as the most accurate "No-Nonsense" guide to protein on the internet. Let’s get better together.

*Disclaimer:

The information provided in this blog is for educational and informational purposes only and should not be construed as medical advice. While every effort is made to ensure accuracy, the content is not intended to replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions regarding your health, medical conditions, or treatment options.

The author is not responsible for any health consequences that may result from following the information provided. Any lifestyle, dietary, or medical decisions should be made in consultation with a licensed medical professional.

If you have a medical emergency, please contact a healthcare provider or call emergency services immediately.

---

Bonus Deep Dive

👵The Grandmother Hypothesis — the leading theory

Why reproductive cessation increases total genetic fitness

Proposed by Kristen Hawkes in the 1990s and supported by decades of anthropological data. The core argument: after a certain age, a woman's marginal contribution to gene propagation is higher through supporting existing grandchildren than through producing new offspring.

The mathematics of fitness: A woman over 45-50 faces significantly higher maternal mortality risk in childbirth, longer inter-birth intervals, and higher infant mortality rates for her own offspring. Meanwhile, her existing children's offspring (grandchildren) survive at much higher rates when a knowledgeable, post-reproductive grandmother is present — gathering food, transmitting knowledge, providing childcare, and freeing younger mothers to reproduce more frequently.

The orca parallel: Female orcas undergo menopause at roughly 30-40 years. Post-reproductive females live to 90+ and specifically lead pod foraging — the oldest females possess irreplaceable knowledge of salmon migration routes across decades. Pods with post-reproductive matriarchs have significantly higher survival rates. The same logic applies: knowledge transfer outvalues direct reproduction after a threshold age. The implication for understanding symptoms: Menopause is evolutionarily adaptive — but it was adapted for a world where post-menopausal women lived perhaps 20 years beyond cessation, were physically active foragers, ate whole foods, maintained strong social bonds, and experienced little of the chronic low-grade inflammation that characterises modern sedentary life. The symptoms we see today are partly the mismatch between the evolutionary design and the modern environment.

🧬The oestrogen withdrawal — what is actually happening hormonally

The single upstream driver of every symptom on the diagram

Menopause is the permanent cessation of ovarian follicle activity. The ovary has a finite number of follicles at birth — approximately 1-2 million, declining to ~400,000 at puberty and near-zero by menopause. As follicles are depleted, oestradiol (E2) and progesterone production fall dramatically. FSH (follicle-stimulating hormone) rises as the pituitary tries to stimulate increasingly unresponsive ovaries — the elevated FSH is the clinical marker of menopause.

The three oestrogens:

Oestradiol (E2): dominant in reproductive years, most potent, produced by ovaries

Oestrone (E1): produced by fat tissue and adrenal glands via aromatase — becomes the dominant oestrogen post-menopause

Oestriol (E3): produced mainly during pregnancy, weakest, minimal role post-menopause

Why oestradiol withdrawal produces such widespread effects: Oestrogen receptors (ERα and ERβ) are expressed in virtually every tissue in the body — brain, bone, heart, skin, GI tract, urinary tract, joints, eyes, and more. Oestradiol is not just a reproductive hormone — it is a systemic anti-inflammatory, neuroprotective, bone-preserving, cardiovascular-protective, and collagen-maintaining signal. Its withdrawal is a systemic event, not just a reproductive one. Every symptom on the diagram maps directly to loss of oestradiol signalling in a specific tissue.

🔥Modern mismatch — why symptoms are worse now than they were designed to be

Ancestral post-menopausal women were lean, physically active, ate whole unprocessed foods, had robust social networks, slept with natural light cycles, and produced meaningful oestrone from lean body fat via aromatase. The transition was designed to be less catastrophic because the hormonal shift occurred against a background of low chronic inflammation, adequate muscle mass, and a microbiome capable of metabolising phytoestrogens.

Modern factors that amplify menopause symptoms:

• Sedentary lifestyle → less muscle → more fat → but paradoxically less oestrone (adipose aromatase is real but fat-cell oestrogen metabolism is dysregulated in obesity, favouring inflammatory oestrone metabolites)

• High-carbohydrate, ultra-processed diet → chronic inflammation → amplifies every oestrogen-withdrawal symptom

• Social isolation → amplifies the neurological symptoms (brain fog, anxiety, depression)

• Inadequate sleep → accelerates cortisol rise that worsens bone loss, brain fog, and weight gain

• Microbiome disruption → impairs enterohepatic oestrogen recycling and phytoestrogen metabolism

• Chronic stress → HPA axis dysregulation → further disrupts the remaining sex hormone production from adrenal DHEA

Mechanism and why oestrogen withdrawal causes it specifically

🌡️ Hot flashes

The most universal and immediate symptom — affects 75-80% of women

Mechanism: Oestradiol stabilises the thermoregulatory set-point in the hypothalamus — specifically by modulating the KNDy neurons (kisspeptin/neurokinin B/dynorphin neurons) in the arcuate nucleus. These neurons fire to trigger GnRH (gonadotropin-releasing hormone) release and also directly regulate the hypothalamic thermostat.

When oestradiol falls, KNDy neurons become hyperactive and dysregulated. Neurokinin B (NKB) from these neurons triggers sudden, inappropriate vasodilation signals — the hypothalamus incorrectly "reads" the body as overheating and initiates heat-loss responses: peripheral vasodilation (the flush), sweating, and heat sensation. The thermoneutral zone (the range within which the body neither sweats nor shivers) narrows dramatically — from several degrees Celsius in reproductive years to nearly zero in menopause, making the system hair-trigger

Why NK3R inhibitors work: New pharmaceutical treatments (fezolinetant) block the NK3 (neurokinin 3) receptor — directly targeting the NKB-KNDy neuron pathway. This confirms the mechanistic model. Non-HRT interventions that reduce NKB signalling or broaden the thermoneutral zone produce the same result via different routes.

🧠Brain fog

Verbal memory, processing speed, executive function — all affected

Mechanism: Oestradiol is neuroprotective via multiple pathways simultaneously. It upregulates BDNF (brain-derived neurotrophic factor) which supports synaptic plasticity and neuronal survival. It enhances acetylcholine synthesis and receptor sensitivity (the memory neurotransmitter). It promotes glucose utilisation in the brain — PET studies show cerebral glucose metabolism falls by ~10-15% in perimenopause, equivalent to what is seen in early Alzheimer's risk. It has anti-inflammatory effects in the CNS, reducing microglial activation.

Without oestradiol: BDNF falls → synaptic density reduces → acetylcholine signalling impairs → cerebral glucose uptake drops → neuroinflammation rises. The result is the subjective "fog" — slower word retrieval, impaired working memory, reduced processing speed. The SWAN study (Study of Women's Health Across the Nation) confirmed that cognitive complaints peak during the perimenopause transition and improve somewhat in the later post-menopausal years as the brain adapts to lower oestrogen.

The dementia connection: Women have disproportionately higher Alzheimer's risk than men (two-thirds of all Alzheimer's cases are women). The oestrogen withdrawal window is now considered a critical period for Alzheimer's risk — particularly the timing of HRT initiation (the "critical window hypothesis"): oestrogen given early in menopause is neuroprotective; given late, it may not be.

BDNF ↓, acetylcholine ↓, cerebral glucose ↓, neuroinflammation ↑Interventions: zone 2 exercise (BDNF ↑), omega-3 DHA (neuronal membrane), lion's mane, RLT transcranial

😟Depression and anxiety

New onset or worsening — even in women with no prior history

Mechanism: Oestradiol modulates serotonin, dopamine, and GABA neurotransmitter systems simultaneously. Specifically: oestradiol upregulates serotonin transporter (SERT) expression and serotonin receptor sensitivity, upregulates dopamine receptor density in the prefrontal cortex and limbic system, and (as we covered with magnesium) potentiates GABA-A receptor function.

Oestrogen withdrawal → serotonin system downregulates → dopaminergic reward signalling blunts → GABA tone reduces → net excitatory shift in limbic system → anxiety, anhedonia, emotional dysregulation. The fluctuating oestrogen of perimenopause (before the final cessation) is particularly destabilising because the brain's neurotransmitter systems are continually adjusting to a moving target — this is why depression and anxiety often peak during perimenopause rather than post-menopause.

Additionally, sleep disruption from hot flashes creates a secondary vicious cycle: sleep deprivation independently amplifies amygdala reactivity and suppresses prefrontal emotional regulation — compounding the direct neurochemical effect of oestrogen withdrawal.

Serotonin ↓, dopamine ↓, GABA tone ↓ → emotional dysregulationInterventions: exercise (serotonin, BDNF), magnesium (GABA), omega-3, ashwagandha, social connection

🦴Bone loss (osteoporosis)

Up to 20% of lifetime bone loss occurs in the 5-7 years around menopause

Mechanism: Bone is in constant remodelling — osteoclasts (breakdown) and osteoblasts (building) are coupled in a balance regulated directly by oestradiol. Oestradiol suppresses osteoclast activity via OPG (osteoprotegerin) upregulation and RANKL suppression — the RANK/RANKL/OPG axis. When oestradiol falls, RANKL is no longer suppressed, osteoclast activity accelerates, OPG falls, and the bone resorption/formation balance tips dramatically toward net loss.

The loss rate is approximately 1-3% of bone mineral density per year during perimenopause and early post-menopause. In absolute terms, a woman can lose 15-20% of her spinal bone density in the decade around menopause. This is why osteoporosis is so disproportionately a female disease — men lose bone slowly throughout life without the acute oestrogen-withdrawal acceleration event.

The calcium story is incomplete: Calcium supplementation alone does not prevent menopause-related bone loss — the problem is increased osteoclast activity, not calcium deficiency. Vitamin D3 + K2 (directs calcium to bone rather than soft tissue), resistance training (mechanical loading stimulates osteoblasts directly — RANKL-independent pathway), and protein adequacy (bone matrix is collagen) are more important than calcium pills.

RANKL ↑, OPG ↓ → osteoclast dominance → 1-3% BMD loss/yearResistance training (most important), D3+K2, protein, magnesium, collagen peptides

⚖️Weight gain — specifically visceral fat redistribution

Not simply "slowed metabolism" — a fundamental change in fat distribution

Mechanism: Pre-menopause, oestradiol promotes fat storage in subcutaneous depots (hips, thighs, breasts) via direct action on adipocyte differentiation. Post-menopause, this oestradiol signal disappears and the metabolic environment shifts: cortisol becomes relatively more dominant, insulin sensitivity falls (oestradiol directly enhances insulin receptor signalling), and the visceral adipose tissue (VAT) depot — which has fewer oestrogen receptors and more androgen receptors — now preferentially accumulates fat.

This is not simply calories in/calories out changing. It is a hormonally driven redistribution from the metabolically safer subcutaneous depot (hips/thighs) to the metabolically dangerous visceral depot (abdominal/organ-surrounding). VAT releases inflammatory cytokines, free fatty acids directly into the portal circulation, and resistin.

Resting metabolic rate: Also falls modestly (approximately 200-300 kcal/day) due to loss of oestradiol's thermogenic effects on brown adipose tissue (oestradiol upregulates UCP1 in BAT) and sarcopenia acceleration (muscle loss accelerates as oestradiol normally preserves muscle mass).

Subcutaneous → visceral fat shift. UCP1 ↓ in BAT. Insulin sensitivity ↓. Sarcopenia ↑.Resistance training (sarcopenia), protein 1.6g/kg, IF, cold exposure (UCP1), zone 2 fasted

💇Thinning hair

Androgen-oestrogen ratio shift — female pattern hair loss

Mechanism: Hair follicle cycling (growth/rest/shed) is regulated by the androgen-oestrogen balance. Oestradiol prolongs the anagen (growth) phase of hair follicles and counteracts the DHT (dihydrotestosterone) effect on scalp follicles. Post-menopause, oestradiol falls while adrenal androgen production (DHEA → testosterone → DHT) remains relatively higher — the ratio shifts.

DHT binds to androgen receptors in scalp follicles → miniaturisation → shorter anagen phases → finer, shorter hairs → eventually follicle becomes dormant. This is the same mechanism as male pattern baldness but typically produces the diffuse thinning pattern characteristic of female androgenic alopecia rather than the male receding hairline — because women have lower absolute DHT levels and different follicle androgen receptor densities.

Additionally, thyroid function (commonly disrupted in perimenopause — oestrogen affects thyroid binding globulin) and iron stores (ferritin below 70 ng/mL impairs hair follicle function) compound the problem.

DHT:oestradiol ratio ↑ → follicle miniaturisationSaw palmetto (5α-reductase inhibitor — blocks DHT conversion), iron optimisation, biotin, collagen, zinc

👁️Dry eyes and mouth

Mucosal oestrogen receptors — secretory gland dysfunction

Mechanism: Lacrimal glands (tear production), meibomian glands (lipid layer of tears), and salivary glands all express oestrogen receptors. Oestradiol maintains the secretory activity of these glands and the mucin content of secretions. Post-menopause, lacrimal and meibomian gland function declines → reduced aqueous and lipid layers of the tear film → evaporative dry eye. Salivary gland output also falls.

Dry eye in menopause is also driven by androgen receptors in the meibomian glands — androgens maintain meibum lipid production, and the relative androgen excess post-menopause paradoxically doesn't protect meibomian gland function because androgen signalling in this gland is complex and not simply dose-dependent. Omega-3 fatty acids (EPA/DHA) are the most evidence-backed intervention — they improve meibomian gland function and tear film lipid quality, reducing evaporation.

Lacrimal and meibomian gland ERα loss → secretory decline → dry ocular surfaceOmega-3 EPA/DHA 3g/day (meibomian), hydration, flaxseed, humidifier

💔Sexual dysfunction

Vaginal atrophy, libido loss, pain — three overlapping but distinct mechanisms

Three distinct mechanisms:

Genitourinary syndrome of menopause (GSM): The vaginal epithelium is oestrogen-dependent. Oestradiol maintains epithelial thickness, glycogen content (which supports Lactobacillus-dominant microbiome), lubrication via Bartholin and Skene gland secretion, and elasticity. Without oestradiol: epithelium thins, glycogen falls, Lactobacillus declines → pH rises from 3.8 to 5.5-7 → dysbiosis → inflammation → pain (dyspareunia), recurrent UTI risk, urinary urgency. This is the most anatomically straightforward symptom and responds best to local treatment.

Libido loss: Both oestradiol and testosterone (produced from DHEA via adrenal and ovarian pathways) drive sexual desire. Both fall at menopause. Additionally, serotonin modulation of dopamine — with oestradiol falling, the dopaminergic reward system for sexual motivation blunts.

Neurological: Oestrogen receptors in the hypothalamus regulate sexual motivation centrally. The same KNDy neuron disruption causing hot flashes also affects the neural circuits governing sexual behaviour.

GSM: vaginal epithelium atrophy. Libido: testosterone + dopamine. Neural: KNDy disruptionLocal oestrogen (topical, minimal systemic absorption), DHEA supplementation, pelvic floor exercise, maca

🧴Dry skin and nails

Collagen loss + sebum reduction + barrier dysfunction

Mechanism: Oestradiol directly stimulates fibroblast collagen synthesis — the same mechanism RLT (Red Light Therapy) exploits via Complex IV. In the first 5 years post-menopause, skin collagen content falls approximately 30% — roughly 2% per year and significantly faster than the 1% per year age-related decline in premenopausal women. Oestrogen also maintains sebaceous gland activity (sebum production), hyaluronic acid synthesis in the dermis (water retention), and the epidermal barrier (tight junction protein expression). All decline with oestrogen withdrawal.

Nail thinning follows similar logic — nail matrix cells express ERα, and nail plate keratin synthesis is oestrogen-modulated. Additionally, longitudinal ridging and brittleness increase as the nail plate hydration is maintained partly by oestrogen-regulated sweat gland activity in the fingertip.

The collagen-protein connection: Collagen synthesis requires adequate protein (particularly glycine and proline from collagen peptides), vitamin C (for prolyl hydroxylase — the enzyme that crosslinks collagen), and silicon (for collagen maturation). Supplementing these around this time produces measurably better outcomes than supplementing in reproductive years.

30% skin collagen loss in 5 years post-menopause. Sebum ↓. Hyaluronic acid ↓.Collagen peptides + vitamin C, omega-3, RLT skin care preset, silica/biosilica, hydration

Diet — phytoestrogens, protein, anti-inflammatory foundation

Food as the primary hormonal modulator available without prescription

Phytoestrogens — the most important dietary class: Plant compounds that bind oestrogen receptors (preferentially ERβ) with approximately 1/100 to 1/1000 the potency of oestradiol. At physiological concentrations they act as weak agonists in tissues where oestradiol is deficient, and as partial antagonists in tissues where oestrogen excess is a concern (breast).

Isoflavones (soy, legumes): Genistein and daidzein — most studied. 40-80mg isoflavones/day reduces hot flash frequency by ~25%, improves bone density markers, and reduces cardiovascular risk markers. Key nuance: equol (the active metabolite of daidzein) is only produced by about 30-50% of Western women — those with the right gut bacteria (Adlercreutzia equolifaciens — the same strain from the Nature paper we discussed). The women who respond best to soy isoflavones are equol producers.

Lignans (flaxseed, sesame): Converted by gut bacteria to enterolactone and enterodiol — weak oestrogenic activity, plus anti-inflammatory effects. 2 tablespoons ground flaxseed daily is the practical dose.

Protein 1.6-2g/kg: Critical for sarcopenia prevention, bone matrix (collagen), and maintaining the metabolic rate. Women in menopause have higher protein requirements than premenopausal women because oestradiol normally enhances muscle protein synthesis efficiency. Without it, more dietary protein is required for the same anabolic signal.

Anti-inflammatory foundation: Mediterranean diet pattern — olive oil, fatty fish, vegetables, legumes, nuts — consistently reduces menopausal symptom severity in RCTs. The mechanism is broadly: lower chronic inflammation → less amplification of every oestrogen-withdrawal symptom.

Reduce: Alcohol (directly worsens hot flashes and HRV, increases breast cancer risk post-menopause), refined carbohydrates (insulin resistance amplified), caffeine excess (hot flash trigger), spicy food (vasodilation trigger).

40-80mg soy isoflavones/day — requires equol-producing microbiome2 tbsp ground flaxseed daily — lignansProtein 1.6-2g/kg — sarcopenia prevention

😴Sleep — the amplifier of every symptom

Poor sleep in menopause is both a symptom and a cause of worsening

Sleep disruption in menopause has three distinct causes that require different interventions:

1. Hot flash-driven awakening: Nocturnal hot flashes (night sweats) are the primary disruptor. Cool sleeping environment (16-18°C — the same advice we gave for brown fat activation), moisture-wicking bedding, and the vasomotor interventions (isoflavones, pollen extract — see supplements) directly reduce this.

2. Oestradiol withdrawal reduces slow-wave sleep: Oestradiol directly promotes slow-wave (deep) sleep architecture and suppresses REM-sleep disruption. Without it, deep sleep compresses and fragmentation increases. Magnesium glycinate (NMDA block, GABA potentiation, melatonin synthesis support), L-theanine (GABA and glycine), and consistent sleep timing are the primary tools.

3. Cortisol dysregulation: Post-menopause, the loss of oestradiol's cortisol-buffering effect means the cortisol awakening response is more pronounced and evening cortisol clearance is slower. Ashwagandha (600mg) is the most evidence-backed adaptogen specifically for cortisol reduction and sleep quality in this context — multiple RCTs including in perimenopausal women.

16-18°C sleep environment. Magnesium glycinate. Ashwagandha KSM-66. Consistent timing.

The evidence-based supplement stack — stratified by evidence quality

Organised from strongest evidence to emerging/supportive. All non-HRT.

Supplement	Dose	Primary target symptoms	Evidence
Soy isoflavones (genistein + daidzein)	40-80mg/day with food	Hot flashes (25% reduction), bone density, cardiovascular markers	Multiple RCTs
Red clover isoflavones (formononetin, biochanin A)	40-160mg/day	Hot flashes, bone, lipids — higher isoflavone variety than soy	Strong RCT data
Omega-3 EPA/DHA	2-3g/day	Dry eyes, depression, cardiovascular, inflammation, brain fog	Strong — multiple indications
Magnesium glycinate	400mg evening	Sleep, anxiety, bone mineralisation, muscle tension	Strong for sleep/anxiety
Vitamin D3 + K2	2000-4000 IU D3 + 100mcg MK-7 K2	Bone density (with resistance training), mood, immune function	Strong for bone
Collagen peptides + Vitamin C	10-15g collagen + 500mg vit C, fasted	Skin collagen (30% loss in 5 years), joint, bone matrix	Good RCT evidence
Ashwagandha	600mg/day	Anxiety, sleep, cortisol, sexual function, hot flash severity	Good — specific peri/menopausal RCTs
Black cohosh (standardised)	20-40mg twice daily	Hot flashes, mood, sleep — most studied botanical for vasomotor symptoms	Moderate — mixed but positive overall
Pollen extract (Relizen/Femal)	120-160mg/day standardised	Hot flashes, sleep — non-phytoestrogenic mechanism (opioid receptor modulation)	Several RCTs, good tolerability
DHEA (low dose)	10-25mg/day	Libido, vaginal atrophy, energy, mood — precursor to oestrogen and testosterone	Moderate — adrenal precursor replacement
Ground flaxseed	2 tbsp/day	Lignans — hot flashes, cardiovascular, hormone metabolism	Moderate evidence
Lion's mane mushroom	500-1000mg/day	Brain fog, BDNF, neuroprotection — NGF stimulation	Emerging — promising early data
Silica/Biosilica	10-20mg elemental silicon/day	Hair, skin, nails — collagen crosslinking cofactor	Moderate for hair/nail quality
Maca (gelatinised)	2-3g/day	Libido, energy, hot flash reduction — non-oestrogenic mechanism	Emerging, small positive RCTs